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Abstract – This review reports how the author has been realizing his synthetic 
philosophy and five dreams as his life work. The philosophy consists of such 
three elements as originality rate, intellectual property factor, and application 
potential factor. On the basis of these elements, an ideal and an efficient synthesis 
are defined. In the study for the total synthesis of ergot alkaloids, the first 
concrete example of an approximately ideal synthesis was demonstrated. Further 
examples are shown relying on the chemistry of 1-hydroxyindoles. A lot of 
intellectual properties created by the author are successfully condensed to provide 
promising lead compounds meeting for the respective dreams of developing five 
drugs 1) for making desert green and food increase in production, 2) for 
cardiovascular system disease, 3) for dementia, 4) for lifestyle-related disease 
(osteoporosis, etc.), and 5) for cancer and virus. With potent promoters of plant’s 
root growth in hand, the first dream is going now successfully. Preliminary 
experiments combating desertification at Gobi desert in Inner Mongolia are 
reported in detail, aiming for preventing global warming.  
1. Introduction 
What kind of article content is judged to have high efficiency and high value in the field of organic 
synthesis? Is the originality evaluated highly if the quality of the research is judged to be high?  Citation 
index and impact factor are usually used as means of the evaluation usefully. However, these numerical 
values are one index for relative evaluation and do not always accord with the originality of the author  
and article content, respectively. 
*Prof. Emeritus. Present Address: 2-40-3 Sodani, Hakusan-shi, Ishikawa, 920-2101, Japan 
We believe the mission of the scientist is to create the intellectual property which transcend the fashion 
and popularity, and the best evaluation/value should be given to the creative power and the intellectual 
property (discovery, invention, and theory) which are brought about by the scientist.1 However, nobody 
has so far proposed an index to measure the rate of originality and intellectual property involved in an 
article.  
Let’s evaluate a general long-step synthesis.1 It is assumed that we achieved N-step synthesis as shown 
in Figure 1 directing toward drug development. In this synthesis the synthetic intermediates of N–1 unit 
are created besides a starting material and a target compound. If only the target compound is the lead for 
a new drug, there exist useless synthetic intermediates of N units involving the starting material. This is 
a typical inefficient synthesis with much waste. From this fact we can understand the way of thinking 
that “evaluation is high because the synthesis has many steps” is meaningless. Nobody doubts to judge 
the short-step synthesis to be superior to the long-step synthesis. 
 
















Intellectual Property of Isolator 
and/or Structure Determinator
If a chemist wish to be evaluated, 
    at least one of the steps should 
         be created by oneself.
Known Reactions
Invented by Others.
The Patent is taken 
by Others.  
 
What is the significance we can claim in achieving the synthesis of the target compound (for example, a 
biologically active natural product) as shown in Figure 1, costing much time, money, and labor, when the 
target compound is the intellectual property of the isolator and/or structural decider? Through the 
synthesis we can educate a beginner and/or a student. They can learn a lot of reaction and technology to 
use in future. But a synthetic chemist who passed the study times would not be satisfied with such 
synthesis. To get evaluation, the synthetic chemist must discover or invent as his intellectual property at 
least one step (a reaction or a reagent) among the N steps. The improvements of the reaction and/or 
reagent created by other researcher are not one's intellectual properties. 
 
2. Our Synthetic Philosophy   
2-1. Originality Rate, Intellectual Property Factor, and Application Potential Factor1  
We have thus far proposed our synthetic philosophy for evaluating the originality and efficiency of 
organic synthesis that consists of three measures such as the originality rate (OR),2a-c the intellectual 
property factor (IPF),3 and the application potential factor (APF).3 By comparing these numerical 
values, we can decide which research or article is excellent regardless of a nation and the times. The 
definitions2 and formulas for calculating OR, IPF, and APF are shown in Figure 2.4 
 
       
The Number of Compound
Having Intellectual Property
IPF = 100 x
2  x  (The Number of Synthetic Steps )  +  1
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2. Intellectual Property Factor (IPF)
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Figure 2. Definitions of OR, IPF, and APF
The Number of Synthetic Steps
Having Intellectual Property
    The Number of Compound Having either 
Biological Activity or Other Useful Functionality
The Number of Synthetic Steps   +    1  
 
OR is the ratio of the following numerator and the denominator. As the former is employed the number 
that added 1 to the total number of the step where a researcher applied a new reaction or a new chemical 
reagent that he created for the first time in the world. As the latter is used the number that added 1 to the 
number of the reaction steps needed for the synthesis. The numerical 1 in the numerator means the 
novelty of the synthetic route. When the synthetic route is known or belongs to other researcher, the 
numeral 1 disappears to zero, while it is left in the denominator. Since every synthetic chemist can 
develop his own synthetic route for the target, OR would be at least more than 1% and never become 
0%. As evidenced by the definition, the OR shows the proportion of the originally developed steps to all 
of the synthetic steps.2-4 
For the calculation of the IPF, the sum of compound and reaction step having intellectual property is 
used as the numerator. While the number that added 1 to the double number of synthetic step is 
employed as the denominator. The IPF is the net rate of one’s own intellectual properties involved in 
every reaction and every compound in the synthesis.3,4   
APF is the sum of application potential of starting material, target compound, and all synthetic 
intermediates.3,4 The numerator is the number of compound having either biological activity or other 
useful functions and the denominator is the number that added 1 to the number of synthetic steps. 
 
2-2. What is an Efficient, Highly Original, and Highly Evaluated Synthesis? 1,2 
We define that an efficient, highly original, and highly evaluated synthesis is the one having high 
numerical value of three indexes: OR, IPF, and APF. In order to raise the OR, researchers are demanded 
necessary device and originality, not an accidental good luck. In this point, our concept is beyond the one 
called selendipity.1,2 Reducing the use of known reaction, researchers should create the original reaction 
and chemical reagent for making the numerator bigger. On the other hand, to make the denominator 
smaller, researchers ought to shorten the synthetic step by creating new reactions, reducing the times of 
using protecting group, and so on. 
OR demonstrates the number of the intellectual property called new discovery and/or knowledge beyond 
the chemical standard of each times that a researcher lived in. Therefore, it is the index that can compare 
the superiority or inferiority over the history. The responsibility as the creator is quite important. 
Through one's life, the creator can keep discovering new properties of matter, function, and 
pharmacological action of his compound.1,2 Therefore, the creator should improve the numerical values 
of IPF and APF.  
The most efficient and ultimate synthesis is the one-step synthesis as illustrated in Figure 3. In the case 
of a long-step synthesis, this ultimate synthesis would pile up. Therefore, the definition of waste free 
“ideal synthetic method” is the one: 1) the numerical values of OR, IPF, and APF are 100%, 2) every 
reaction employed for the synthesis is the intellectual property of the researcher, 3) every synthetic 
intermediate, including starting material and the target compound, has pharmacological activity or some 
kind of function. An efficient synthetic method is the one that has higher numerical values of OR, IPF, 
and APF.1,2 
Original “synthetic philosophy” was newly born in this way. However, the severest criticism was the 
following: since anyone could propose only a theory, “show a concrete example”. On the basis of the 
above philosophy, we had started challenging studies aiming at the realization of our “five dreams”. 
They are the development of drugs 1) for making desert green and food increase in production, 2) for 
cardiovascular system disease, 3) for dementia (senile dementia), 4) for lifestyle-related disease 
(diabetes, osteoporosis, etc.), and 5) for cancer and virus.  
In order to create the concrete examples of approximately “ideal synthetic method” without waste with 
high OR, IPF, and APF values1,3-5 and to achieve the above five dreams at the same time, 30 years (the 
time to the brink of the retirement) were necessary from the proposal of our synthetic philosophy. 
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1. Originality Rate (OR)                                             
2. Intellectual Property Factor (IPF)  
3. Application Potential Factor (APF)
= 100%  
= 100%  
= 100%  
 
3. A Study Aiming at Creating an Ideal Synthetic Method for Ergot Alkaloids as a Target  
A lot of drugs and biologically active compounds are known among ergot alkaloids and their 
derivatives.6 Therefore, we started the synthetic project for ergot alkaloids with an aim to create an 
example of synthetic method with high OR and, at the same time, to realize some of our dreams. The 
key point whether or not we could achieve the synthesis depends on whether we could develop new 
synthetic method of 4-substituted indoles which had been hardly accessible in indole chemistry. 
 
3-1. Strategy and Reality for Creating New Synthetic Methods of the 4-Substituted Indoles   
Theoretical consideration suggests us three ways of strategy to create new synthetic methods for 
4-substituted indoles (Scheme 1).2a The first strategy employs ring transformation. Utilizing the active 
peri position in the bicyclic aromatics, we can prepare the compound as shown in a general formula (1, 
N is an appropriate nitrogen containing functional group). Subsequent reduction transforms an A=B part 
to the X-Y group giving the dihydro-compound (2). For example, when Y is a nitrogen atom, an 
enamine structure is formed. So, the introduction of a formyl group onto the 4-position can be realized to 
give 3. In the next stage, proper transformation of the N functional group would produce 
3,4-disubstituted indoles (4).  
The second strategy uses benzene derivatives. Suitably functionalized benzene derivatives (5) are 
produced initially. The compound (5) is provided alternatively from the intermediate (2) of the first 
strategy. Subsequent oxidation changes a styrene part into an acetaldehyde (6). The transformation of the 
N functional group into an amine equivalent spontaneously forms the pyrrole ring. As a result we can get 
4-substituted indoles of type 7. The third strategy employs the coordination chemistry of the metal. 
Using indoles of type 8 as a ligand in which suitable functional groups are arranged at the 1 and/or 3 
positions, functionalization at the 4-position is made possible to give 9. This compound can be provided 
from 5 of the second strategy. After fixing a functional group properly we can obtain 4-substituted 
indoles of type 10. If we choose a suitable atom or a functional group to the respective N, A, B, X, Y, X', 
Y', L, and W in the general formula, and try a suitable combination in turn,2a we would be able to create 
various and a lot of new synthetic methods for the 4-substituted indoles. 
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As the first concrete example, the compound (2) was examined where the combination of N=NO2, 
X=CH2, and Y=NMe is chosen. The initial heteroaromatic compound (1) is therefore 5-nitroisoquinoline. 
We employed 2-methyl-5-nitroisoquinolinium iodide (11) as a starting material (Scheme 2). 
Reduction of 11 provided unstable 1,2-dihydro-compound (12a).7 Application of the modified Vilsmeyer 
reaction successfully introduced formyl group into the 4-position, an active site of enamine part, 
affording a stable crystalline compound (13a). Subsequent treatment of 13a with triethyl phosphite gave 
lactam (14a). It was too labile to purify and oxidized to tar during work-up. Therefore, crude lactam 
(14a) was reduced with diborane without purification culminating in the formation of 15a. Alternatively, 






















a) R = H; b) R = CH2COMe; c) R = CH2











The first strategy described in Scheme 1 worked well even in the case of the 1-substituted isoquinoline 
(X=CHR, Y=NMe).7 Thus, the 1,2-dihydrocompound (12b) was obtained by the addition of acetone to 
the 1-position of 11. Subsequent above-mentioned Vilsmeyer reaction led 12b to 13b. After protection 
of the ketone part of 13b as a ketal group, treatment of 13c with triethyl phosphite, followed by the 
reduction with diborane, produced 4-substituted indole (15c) through lactam (14c). High pressure 
catalytic hydrogenation of 13c was also successful to provide 4-substituted indole (15c) in good yield.  
As for X and Y in 2, the respective combinations of NH, NH (1,2-dihydrocinnoline),8 C=O, O 
(isocoumarin),9 and CH2, O (isochroman)10 were examined culminating in the formations of 
4-substituted indoles in good yields, respectively. Consequently, at one sweep as scheduled, we 
succeeded in creating many new synthetic methods for 4-substituted indoles as our intellectual properties. 
More informations including other methods are referred to our review.2a,b 
 
3-2. Our First Total Synthesis of 6,7-Secoagroclavine by Fifteen Steps 
Ergot alkaloids’ family consists of compounds having several different types of structure. For achieving 
total syntheses of all types of the alkaloids, we chose 6,7-secoagroclavine (16, Scheme 3) as a common 
synthetic intermediate. As the first step in the synthesis of 16, we created a new reaction for the 
preparation of 4-methylaminomethylindole (17) from 2-methyl-5-nitroisoquinolinium iodide (11) by 
treating with titanium (III) chloride,11 according to the first strategy shown in Scheme 1. In the second 
step, direct oxidation of 17 was carried out affording indole-4-carbaldehyde (18). Subsequent aldol 
reaction with acetone, followed by Mannich reaction led 18 to gramine derivative (19). The next step is 
the reaction of 19 with nitromethane. 
Generally speaking, the reaction of gramine (20) with nitroalkanes generated trimer (21) and dimer (22) 
as shown in Scheme 4. No one achieved the selective production of monosubstituted nitroalkanes (23) in 
those days. We needed only gramine (24) corresponding to 23 and examined various attempts in search 
of the objective reaction. Finally we conceived the idea to utilize the coordination chemistry and the 
basicity of the phosphorus atom. As a result, we could create the new reaction with tri-n-butylphosphine 
as a catalyst to attain the predominant synthesis of 23.12 Later, this new reaction is used widely for the 






































































































15 Steps: OR = 3/16 = 19%
a) R = Ms
b) R = OH R = OH,TiCl3















Scheme 4. Reaction of Gramine with Nitroalkanes
New Reaction
NMe2

















The above reaction was applied to the reaction of 19 with nitromethane. As expected, 19 generated 24 
selectively as an intermediate and subsequent ring closure occurred simultaneously to give a 1:3 mixture 
of 4,5-cis- (25) and 4,5-trans-1,3,4,5-tetrahydrobenz[cd]indoles (26).13 After application of a series of 
known reactions to 26, we achieved our first total synthesis of (±)-6,7-secoagroclavine (16) through 27a 
and 28a.12 This synthetic method requires 15 steps from 11 to 16 and includes two our reactions. 
Therefore, OR of this synthesis is calculated to be 100x(2+1)/(15+1)=19%. 
 
3-3．Total Synthesis of 6,7-Secoagroclavine by Eight Steps 
We were not able to be satisfied with the OR of the synthetic method shown in Scheme 3. In addition, 
from a standpoint as a critic we do not feel brilliance and creativity about the seven steps reaching 27a 
from 26. Moreover protection groups are used twice. Consequently protection and deprotection steps 
necessarily make the synthetic steps long. Six steps can be shortened at one sweep and OR rises high if 
we can create the short cut that can convert 26 into 27a by one step. 
On the basis of this idea, we transformed the target (27a) to the synthetic equivalent (27b). If we could 
imagine electron surplus organometalic cluster (29) in close vicinity of a nitro compound as shown in 
Scheme 5, the nitro group easily receives electrons and the substrate would be reduced to a nitroso 
compound (32) through 30 and 31. In case where the substrate has both nitroso and carbonyl groups in a 
molecule at the same time, alkyl group of 29 could add to them resulting in the formation of the 
expected 33 (namely 27b). 
 
Scheme 5. Design for New Introduction of Alkyl Group to Nitroalkanes
M—M—M—M
Cluster
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We chose Grignard reagent among various candidates of organometalic cluster (29), which is imagined 
to have both ability to generate methyl anion and to reduce the nitro group. After having repeated trials, 
we succeeded in discovering that 30－50 times of excess methylmagnesium iodide worked well as we 
expected, resulting in the formation of about 15% yield of 27b.14 Subsequent dehydration, followed by 
the reduction of the resultant hydroxylamine (28b) with titanium (III) chloride provided 16. Thus, an 
eight-step synthetic method was completed. Because an extra new reaction makes it possible to shorten 
the fifteen steps to eight steps, the OR of this synthetic method is 100x(3+1)/(8+1)=44%. In addition, 
IPF became 100x(4+3)/(2x8+1)=41% realizing a good level because 19, 25 (and 26), 27b, 28b were our 
compounds. However, APF was still low and this is the reason why we were not satisfied with this 
synthetic method either. 
 
3-4. More Efficient Total Synthesis of 6,7-Secoagroclavine by Seven Steps  
Creation of the new reaction suitable for meeting the purpose is necessary for making the synthetic step 
short. According to the third strategy (a metal coordination chemistry) in Scheme 1, we tried various 
reactions on the industrial raw material (34, Scheme 6) as one of the candidate of 8 and finally 
succeeded in discovering the desired reaction. Thus, the reaction of 34 with mercury (II) trifluoroacetate 
generated organomercuric compound (35). Without purification, the crude 35 was treated with olefins in 
the presence of Pd catalyst to give the corresponding 4- and 5-substituted indoles. When the crude 35 










































Scheme 6. Synthesis of 4-Substituted Indoles by Metalation
67%80%93%66%



























a) R' = NO2, b) R' = NH2
OH39 40 41 42 43




We had to create authentic 37, however, by a reliable alternative synthetic method to get the evidence 
that 37 has the correct 4-substituted indole structure. According to the second strategy in Scheme 1, we 
selected 2,6-dinitrotoluene (38a) as a concrete candidate of 5. Treatment of 38a with dimethylformamide 
dimethyl acetal, followed by the reduction with 6 mol eq. of titanium (III) chloride, which is one 
electronic reducing agent, provided 4-nitroindole (40) in good yield.16a,b When 4 mol eq. of titanium (III) 
chloride was employed at the reduction step, we were able to get 1-hydroxy-4-nitroindole (39a) as main 
product.16a Similarly, 39b and 40b were produced when starting material was changed to 38b. 
By the way, nobody succeeded in the production of useful chemicals upon the reaction of 
3-nonsubstituted aminoindoles with nitrous acid. Diazotization of them generated only tars so far and the 
attempt was believed to be a taboo in the indole chemistry. To overcome the problem, we tried to lower 
the electron density at the 3-position and to regulate the reactivity introducing electron withdrawing 
group into the 1-position (indole nitrogen). Thus, 40a was converted to 41a and then reduced to 41b. By 
modifying the operation of the Sandmeyer reaction with potassium iodide, we succeeded in diazotization 
of 4-aminoindole (41b) to produce 1-substituted 4-iodoindole (42) in high yield.16b Afterwards this 
diazotization reaction is used often by synthetic chemists in the indole chemistry. 
Alkaline hydrolysis of 42 afforded 4-iodoindole (43). Subsequent Vilsmeyer reaction produced the 
desired authentic sample of 4-iodoindole-3-carbaldehyde (37). This authentic sample was identical with 
37 obtained by the reaction with mercury (II) trifluoroacetate.16a,b 
In inorganic chemistry, Hg, Tl, and Pb are well known to have similar properties. Since we found new 
synthetic method for 4-substituted indoles employing Hg chemistry, we next planned to examine Tl and 
Pb chemistry.   
One day in a journal of the current issue, we found the report by Hollins’ group that the compound (37) 
was regioselectively produced from 34 by the reaction of (3-formylindol-4-yl)thallium 
bis(trifluoroacetate) (44) with potassium iodide (KI) in an overall yield of 39%.17 We were disappointed 
very much because we were not the first creator of 37. To our surprise, however, their structure 
determination is merely based on the NMR spectral data. In those days, synthesis of 4-substituted 
indoles was difficult as stated thus far in this review. Therefore they could not identify by comparing 
their compound with the authentic sample, leaving a slight possibility to be a 7-substituted indole. We 
did a supplementary examination of their method. We then compared their product (37) with our 
authentic sample and could determine the structure, unequivocally. Furthermore, we found that when a 
combination of copper (I) iodide and iodine, instead of KI, was employed to the reaction of 44, the 
iodination occurred quantitatively. Consequently we were able to improve Hollins’ reaction and provide 
37 in 72% overall yield from 34.18 
Applying the improved Hollins’ reaction, we were able to establish a practical total synthetic method of 
6,7-secoagroclavine (16) in seven steps as shown in Scheme 7. It is worthy to note that in this synthetic 
method, we do not use any protective group at all. This is the first example based on the concept called 
“total synthesis without using the protective group”.19 In addition, we improved Heck reaction 
employing a phase transfer catalyst20 in the synthesis of 45 from 37. Furthermore, a new ring closure 
reaction of 46 to 47 is invented by the addition of NaBH4 into a MeOH solution of 46, followed by the 
dripping of the resultant reaction mixture into an aqueous HCl. Consequently, OR of this synthetic 








































34 37 45 46
474816
(Heck reaction with 
phase transfer catalyst)
Improvement
Scheme 7: Seven-Step Synthesis of (±)-6,7-Secoagroclavine
Overall Yield: 36%; OR = 2/8 = 25%
 
On the other hand, Kamuro brought us a report stating that the compound (37), originated from 
diazonium salt of 41b, has strong plant growth stimulation effect.19 Watanabe reported us that 48 and its 
N-alkyl derivatives are dopamine agonists.19 Since we found that 37 and 48 have useful pharmacological 
activities, values of APF and IPF are 100x2/(7+1)=25% and 100x1/(2x7+1)=7%, respectively. As a 
result, we could demonstrate the substantial example of three indexes of our synthetic philosophy.  
 
3-5. Total Synthesis of Aurantioclavine and Clavicipitic Acid Having Seven Membered Ring 
Structure 
Total syntheses of aurantioclavine20a,b (49a) and clavicipitic acid21 (49c), belonging to ergot alkaloids 
having seven membered ring structure, were achieved by the following synthetic method with high OR 
as shown in Scheme 8. As the first step we created new reaction to change indole-3-carbaldehyde (34) 
into gramine (20) by one step.22 Application of the reaction to the 3-formyl group of 45 afforded gramine 
(50). The second step is our reaction as well. Thus, treatment of 50 with nitromethane and methyl 
























































     a) R = H
          aurantioclavine
b) R = CO2Me
c) R = CO2H













Next we designed a new reaction to get the alkaloids (49a,b) having seven membered ring by generating 
a stable cation on the side chain at the 4-position of 51a and 51b, followed by simultaneous reduction of 
nitro group in an acidic condition. When the nitro group is reduced to the amine stage, rapid protonation 
is expected to occur giving 52 and the amine loses its nucleophilic character resulting in the failure of 
ring formation. If a reducing agent promise a long lifetime of the hydroxylamine stage, a desirable 
synthetic intermediate (53) generates, and the formation of seven membered ring is expected. Based on 
this idea, we tried reducing agents in various ways on 51. As a result, we found that amalgamated 
zinc/HCl is a reagent of choice to produce 49a and 49b in good yields, respectively, through the 
respective unstable 54a and 54b. The conversion of 49b to clavicipitic acid (49c) was already achieved 
by late Natsume group.23 
 
3-6. New Synthetic Methods for the 4-Substituted Indoles Based on the Metal Exchange 
Mechanism2b 
To raise the OR, we conceived the idea to get a product of 56 type by converting the C—Tl bond of the 
thallium compound (55 type) into C—C bond directly (Scheme 9). Palladium catalyzed reaction such as 
Heck reaction, Stille reaction, etc. were reported and their reaction mechanisms were suggested in the 
literatures. We imagined a totally different mechanism in which metals in the carbon-metal bond could 
exchange freely among thallium, palladium, and other metals.  
In fact, we could create the desired C—C bond forming reactions as imagined by reacting 55 with 
organometals in the presence of palladium catalyst as shown in Scheme 9.24 We called the palladium 
catalyzed reaction of thallium compound (55) with olefins producing 56 “thallation-palladation 
reaction”.25 Similarly, we named the palladium catalyzed reaction of 55 with boron reagents, tin reagents, 
and silicon reagents boronation-thallation (bo-thall) reaction,26 stannation-thallation (tin-thall 

























2. Boronation-Thallation (Bo-Thall) Reaction












R Olefins (Functionalyzed, Substituted, etc.)
R B(OH)2 Boronic Acids, Boron Containing Compounds
R SnR3 Tin Containing Compounds
R SiR3, R SiF5K2
4. Silation-Thallation (Si-Thall) Reaction
Silanes and Silicates
55












R, R1-3: an appropriate substituent
 
3-7. Four-Step and Approximately Ideal Synthetic Method of 6,7-Secoagroclavine: The Shortest 
Synthesis in the World 
We could create various new synthetic methods for 4-substituted indoles based on the metal exchange 
mechanism as planned in the third strategy in Scheme 1. We decided to apply the tin-thall reaction as the 
first step to the total synthesis of 6,7-secoagroclavine for establishing an efficient and highly original 
synthesis. When the compound (44) was reacted with tin reagent (57, Scheme 9) the successful 
production of 45 was observed in 49% yield. The isolation of 44 was not necessary. After evaporation of 
the solvent of the reaction mixture of 34 with thallium (III) trifluoroacetate, the resultant residue was 
reacted with 57. This convenient one-pot tin-thall reaction worked well and the overall yield was 49% as 























Overall Yield = 19%. OR = 4/5 = 80%










In the fourth step (Scheme 10), we applied new Grignard reaction to 47, which was developed in the 
transformation of 26 → 27b (Scheme 3). Without isolating the resultant methyl hydroxylamine 
derivative, the reaction mixture was treated immediately with Zn/HCl. This new one-pot reductive 
Grignard reaction produced the desired methylamine (16).29 As a result, we succeeded in shortening the 
total synthesis of 6,7-secoagroclavine (16) to four steps from 34. This means the birth of the shortest and 
efficient synthetic method of 16 approximately without waste.29 
Among the four steps, our intellectual properties are accumulated in three steps. Therefore, OR is 
100x(3+1)/(4+1)=80% which is close to an ideal. Since 16 became readily available, it is no more 
synthetic target. It is now a raw material of the derivative synthesis for the drug development. We 
therefore introduced various substituent into N(6) of 16, and produced various derivatives for the 
structure-activity relationship study. Although biological activity of 16 was not reported, we have newly 
found that 16 and its derivatives are potent dopamine agonist.30 Accordingly, APF is 100x1/(4+1)=20%, 
while IPF becomes 100x(3+1)/(2x4+1)=44%. 
 
3-8. Highly Efficient Total Synthesis of Chanoclavine-I  
Total synthesis of chanoclavine-I (58) had been reported untill the late 1980s by four groups as shown in 
Scheme 11. Plieninger group31 achieved its total synthesis by 13 steps from 2-aminonaphthalene. 
Oppolzer32 and Kozikowski33 groups utilized 2-methyl-3-nitrobenzoic acid as the starting material and 
they elaborated the total synthesis in 17 and 14 steps, respectively. In addition, late Natsume group34 
accomplished 19-step synthesis from 1-methoxycarbonylpyrrole.   
With 47 in hand in 3 steps from bulk chemical (34), we tried the oxidation of isobutenyl side chain at the 
4-position of 47 with selenium dioxide. The resultant aldehyde (59) and alcohol (60) were interconverted 
easily. Subsequent reduction of 60, followed by the conventional two-step reaction, resulted in the total 
synthesis of chanoclavine-I (58) through norchanoclavine-I (61).35 Thus, seven-step synthesis of 58 from 










































dioxane Our Synthesis      7 steps
Plieninger Oppolzer Kozikowski Natsume
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3-9．Development of an Efficient and Common Synthetic Method for All Types of Optically Active 
Ergot alkaloids 
If we could employ optically active 4,5-trans- and 4,5-cis-compounds, 47 and 62, respectively, as 
common synthetic intermediates (Scheme 12), we would be able to develop an efficient and common 
synthetic method for all types of optically active ergot alkaloids. Based on the idea, we first found the 
reaction conditions for the interconversion of (±)-4,5-trans-47 and (±)-4,5-cis-62. Examination of the 
optical resolution of each compound was then carried out with a Chiralpak AS column of Daicel 
Chemical Ind. Ltd. As the separation patterns are shown in Scheme 12, we could find the conditions to 














benzene, Et3N, reflux, 16.5 h
85%45 45
(±)-4,5-cis-62
Scheme 12. Chemical Conversion and Optical Resolution of 5-(2-Methyl-1-propen-1-yl)-4-nitro- 

























2) Zn, HCl, MeOH
      (+)- 6,7-secoagroclavine
      mp 137.5-139.0°C
55%
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Scheme 13. The First Total Syntheses of (–)- and (+)-6,7-Secoagroclavine 
                                    and Its Absolute Configulation
1)  MeMgI
     (30 mol eq.)
(–)-enantiomer
(+)-enantiomer
[α]D25 +211.3° (c 0.23, EtOH)
[α]D25 –212.6° (c 0.35, EtOH)
Lit., mp 126-129°C
     (–)- 6,7-secoagroclavine
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1)  MeMgI
     (30 mol eq.)
 
Furthermore, employing preparative chiral column chromatography, a large quantity of (–)-4,5-trans-47, 
(+)-4,5-trans-47, (–)-4,5-cis-62, and (+)-4,5-cis-62 were obtained.36 In addition, we had a plan for 
making possible the interconversion among optically active isomers. Thus, once the compound (63) is 
produced from 47 and 62, subsequent elimination of HX introduces double bond into the 4,5-positions to 
give 64. Subsequent partial reduction or enantioselective reduction would return it to 47 and 62 or their 
optical isomers. However, at present, this plan is not examined because of my retirement.  
We then determined the absolute structure of the natural product, (–)-6,7-secoagroclavine ((–)-16) as 
shown in Scheme 13. Thus, one-pot reductive Grignard reaction was applied to (–)-4,5-trans-47 and 
(+)-4,5-trans-47 to provide (–)- ((–)-16) and (+)-6,7-secoagroclavine ((+)-16), respectively. Subsequent 
reaction of (–)-16 with (R)-(+)-MTPA yielded crystalline (+)-65 which was suitable for the X-ray single 
crystal analysis and the results are shown in Scheme 13. The absolute configuration of (+)-MTPA is 
known to be R. Therefore, the absolute configurations thus far unknown at the 5 and 10 positions of 























mp 179.5-181°C, [α]D25 +211°
 (c  0.505, pyridine)
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mp 183.5-185°C, [α]D25 –213° (c  0.500, pyridine)









Total synthesis of (–)- ((–)-66) and (+)-isochanoclavine-I38 ((+)-66) were achieved by merely reacting 
(–)-16 and (+)-16 with selenium dioxide, respectively (Scheme 14). This new reaction was designed to 
form an intermediate (67) relied upon the coordination effect of the 4-methylamino group of 16 to 
selenium dioxide. The reaction probably proceeds as planned by the reaction mechanism passing 
through intermediates, 68, 69, and 70 from 67. 
In the next step as shown in Scheme 15,  (–)- ((–)-66) and (+)-isochanoclavine-I ((+)-66) were reacted 
with phosphorus oxychloride in the presence of base. As a result, syntheses of both (–)- ((–)-71) and 
(+)-agroclavine ((+)-71) were achieved successfully.39 
Above-mentioned various reactions were successfully applied to every corresponding 4,5-cis-compound: 
such as (±)-, (–)-, and (+)-4,5-cis-62. Accordingly, total syntheses of chanoclavine-II, isochanoclavine-II, 
and agroclavine-I, which are ergot alkaloids belonging to 4,5-cis family, were achieved as (±)-,2b,40 (–)-, 























cis: R = β-H
trans: R = α-H
Scheme 15: The First and Simple Total Syntheses of Ergot Alkaloids, (–)-6,7-seco-
agroclavine,  (–)-Isochanoclavine-I and (–)-Agroclavine, and Their (+)-Enantiomers
 (–)- and (+)-
agroclavine
  (–)- and (+)-
isochanoclavine-I
 (–)- and (+)-6,7-
secoagroclavine
  optical 
resolution




















In this way we succeeded in establishment of the efficient and common total synthetic method for ergot 
alkaloids from 34 as summarized in Scheme 15. Large quantities of four kinds of optically active 
isomers of 47 and 62 are available by the preparative chiral chromatography. Then, using conventional 
reagents and employing common route without any protective groups, (–)- and (+)-isomers of 16, 66, 
and 71 and their corresponding 4,5-cis-family compounds are now available.41 Regardless of trans, cis, 
and optically active isomers, ORs of 16, 66, and 71 are 80, 83, and 71%, respectively.  
We could not be satisfied with this synthetic method because the synthesis of agroclavine (71), one of 
the tetracyclic ergot alkaloids, required still 7 steps from 34. For lysergic acid (72) synthesis, extra 2 
steps would be predicted. For starting a study for drug development with tetracyclic ergot alkaloid as a 
raw material, we must devise a new reaction to further shorten the synthetic steps. 
In the tin-thall reaction of 34 as shown in Scheme 16, we employed 73 as a tin reagent which has a 
suitable pyridine nucleus.42 After trials we found the reaction conditions to obtain the desired product 
(74) from 34 in good yield accompanied by 75.39 It is interesting to note that when a phase transfer 
catalyst was employed as an additive, the yield of 74 was greatly improved as shown in the Table. This 
phenomenon is observed in the improved Heck reaction as mentioned before.20 Compound (74) has all 
atoms needed to build the target (72) except one carbon atom. The problem left unfinished is the C—C 
bond formation between the 3-formyl group and the 2-position of pyridine nucleus, introducing one 
carbon onto the nitrogen of pyridine. Once the desired reaction is realized, tetracyclic ergot alkaloids 
would be available within 4 steps from 34 and we believe a lot of biologically active compounds will be 
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Attempt: less than four steps






















4. Total synthesis of Marine Alkaloid with High OR 
With two purposes to realize our dream and to demonstrate more examples of the concept named 
originality rate (OR), we chose batzelline C44 (76) and isobatzelline C44 (77) (Scheme 17) as target 
compounds. These are members of biologically active marine alkaloid having 
1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline as a common skeleton.   
At first we created a group of new reaction to convert the C—Tl bond at the 4-position of the thallium 
compound (44) into both a C—O and a C—N bond, at one’s will.45 Employing this new reaction, 
4-nitroindole-3-carbaldehyde (78) was obtained from 34 in 65% yield in one-pot. Subsequently our new 
reaction,22 converting indole-3-carbaldehyde into gramine, was applied to 78 resulting in the formation 
of 3-dimethylaminomethyl-4-nitroindole (79).  
After leading 79 to 4-nitroindole-3-acetonitrile (80), we tried a catalytic reduction according to Hester’s 
reaction conditions46 in order to get 1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline (81), but in our hand it 
was failure. By improving the reduction conditions to carry out under high pressure with heating, the 
desired 81 was obtained in good yield.43 Subsequent treatment of 81 with acetic anhydride afforded 82a. 
We challenged to develop new reaction for converting indole-3-carbaldehyde into indole-3-acetonitrile 
in one pot in order to shorten the reaction step, and succeeded in the creation of the desired reaction.22 
Application of the reaction to 78 produced 80. Subsequent high pressure and high temperature catalytic 
hydrogenation in the presence of acetic anhydride provided 82a in one pot. We consequently succeeded 
in shortening the reaction step by 2 steps.47 Further applications of a series of known reactions to 82a led 

























































































In order to introduce a nitrogen or an oxygen containing functional group into the 7-position of 84, we 
thought of the application of the redox system of quinone-hydroquinone structure. If we employ 
benzylamine as a nucleophilic reagent for 84, the resultant 7-benzylamine (85) would be oxidized 
simultaneously to 7-benzylideneamine (86). This new reaction was realized as expected and generated 
batzelline C (76) and isobatzelline C (77) in 10 and 41% yields, respectively. Unexpectedly, we proved 
that isobatzelline C, the natural product, is the protonated form of 77 instead of the free base.47 
Yamamura group48 achieved the total syntheses of 76 and 77 in 19 and 18 steps, respectively. Our 
synthesis requires only 8 steps47 and its OR is 100x(3+1)/(8+1)=44%, because the reactions such as 34
78, 78→79, 78→80, 84→76+77 are our intellectual properties. 
“Ideal Synthetic Method” Aiming at Our Five 
iral compound is chosen, optically active and suitable starting 
thetic method” as shown below in response to the demands that had been criticized for many 
s.   
→
 
5．Creation of the Waste Free and Approximately 
Dreams1,4,5 
We have thus far studied aiming at realizing our five dreams by the creation of waste free “ideal 
synthetic method” fusing the following two thoughts: the one is our synthetic philosophy based on OR, 
IPF, and APF and the other is our synthetic principle we always have in facing synthetic work for drug 
developing. The principle consists of the following 9 elements. 1) Synthesis should be simple. 2) Starting 
material should be cheap possessing the possibility of mass production. 3) Target is recommended to 
have mother skeleton belonging to a living body required ingredient. 4) Conventional chemical reagents 
under normal conditions should be employed. 5) Molecular weight of the target is recommended to be 
less than 500 and if possible it should be around 300. 6) Reactions, synthetic intermediates, and target 
compounds should be one’s own intellectual properties. 7) High yield of each synthetic step and high 
overall yield are required. 8) High selectivity of each reaction should be attained. 9) Target is desirable 
not to be a chiral compound. If a ch
material should be readily available.  
We now succeeded in creating three satisfactory concrete examples of the approximately waste free 
“ideal syn
year
   
5-1．Creation of the First Concrete Example1   
It took ten years to create the first concrete example. The project progressed by creating new reaction to 
reduce indigo (87) to 2-acetoxy-2,2’-bisindole (89) in high yield,49 although no one succeeded in the 
reduction of 87 to a useful synthetic intermediate thus far (Scheme 18). Employing the reaction as the 
first step, we established50 a 59% overall yield and 6-step synthetic method for the antibiotic, 
6-cyano-5-methoxy-12-methylindolo[2,3-a]carbazole (88) which was discovered by Knübel group.51    
In this synthesis, the following reactions such as 87→89, 90→91, 92→93 and 90, 91, 92, and 93 are our 
new reactions and compounds, respectively. The compound (91) is an α2-blocker while 90, 92, and 93 
are lead compounds as inhibitors of platelet aggregation. These intellectual properties are now under 
patent application. Indigo has been known and used as the dye from the ancient times, and the compound 
ed in creating one concrete example of the 
pproximately waste free and “ideal synthetic method”.1  
 
(89) is an inhibitor of telomerase as reported by Sasaki group.52 
Let’s evaluate this synthesis. Every compound such as starting material, target compound, and synthetic 
intermediate has either pharmacological activity or a useful function, and all compounds have possibility 
of practical use and/or the commercialization. Therefore, OR, APF, and IPF of the synthetic method are 
57, 54, and 100%, respectively. In this way, we succeed
a





































































However, both the target compound and the compound (89) are intellectual properties of Knübel and 
asaki, respectively. We were not satisfied with the fact based on our synthetic philosophy.  
in the way to achieve the second 
S
 
5-2．Creation of the Second Concrete Example4 
A target compound must be one's intellectual property again to get closer to the ideal. It took 25 years to 
create the chemistry of 1-hydroxytryptophan and 1-hydroxyindole which was a domain in the 
imagination.53 After opening the door to the thus far unknown domain, we have discovered a lot of new 
reactions and new findings.53 As a result, the obstacle that stood 
concrete example disappeared at one sweep as shown in Scheme 19. 
The second concrete example is an approximately waste free and “ideal synthetic method” of 95 and 96 
from the bulk chemical, tryptamine (94), in 6 steps with an overall yield of 38—48%.4 At first, 
2,3-dihydrotryptamine (98) was prepared from tryptamine (94) through 97. Subsequent application of 
our 1-hydroxyindole synthetic method to 98 provided the corresponding 1-hydroxytryptamine (99). In 
indole chemistry only electrophilic substitution reactions were known thus far.54 Nevertheless, we could 
establish nucleophilic substitution reactions against common sense.55 Application of the new 
nucleophilic substitution reaction to 99 in MeOH produced N-acetyl-5-methoxytryptamine (100) in high 
yield. Next, we found selective tribromination of 100 under suitable brominating conditions to give 
tribromomelatonin (101).55 Subsequent introduction of an appropriate appendage onto the 1-position of 
e 
steoporosis therapeutic drug. We referred them to SSH-BM-I and -II compound group, respectively. 
 
101 afforded 95, 96, 102, and so on. 




























































R1 = an appropriate substituent
94 97 98 99
104105100101
102 95 96











For the evaluation of them, we applied our original assay method with the scale of the goldfish, 
developed by the coworkers, Hattori and Suzuki.4 In addition, compounds, 97, 101, and 102, were 
discovered to be new α2-blockers by the cooperation of Shigenobu and Tanaka.4 The potency of these 
compounds is equal to yohimbine, and it became clear to be the leads for the erectile dysfunction 
therapeutic drug. We named these SST-VED-I, -II, and -III compound group. The synthetic 
intermediate (99) is a new inhibitor of platelet aggregation that is stronger than cilostazol (103). 
Therefore, 99 is a group of lead compounds for the treatment of cerebral infarction and the myocardial 
infarction.4 The compound (100) is melatonin and is multimodality having various biological activities. 
Synthetic intermediates, 104 and 105, involved in the alternative route to 100 from 99, have also 
pharmacological activity, respectively. In conclusion, every compound in the synthesis, including 
starting material, intermediates, and target compound is biologically active. The reactions such as 98→
9, 99→100, and 99→104 are our original new reactions. Therefore, OR, APF, and IPF of the synthetic 
her 
ond cleavage reaction of 108. Fortunately, we discovered the desired reaction treating 108 with 
1,4-diazabicyclo[2,2,2]octane resulting in the formation of 1-hydroxyindole-3-carbaldehyde (109).  
 
9
method are 43, 54, and 100%, respectively.1,4 
 
5-3． Creation of the Third Concrete Example5 
The third concrete example has OR, APF, and IPF value of 80, 55, and 40%, respectively as shown in 
Scheme 20. Based on our 1-hydroxyindole chemistry,53 indoline (106), one of industrial raw materials, 
was converted to 1-methoxyindole (107), which was further converted to 












1) Na2WO4·2H2O, 30% H2O2
2) Me2SO4





























In the next step, we needed to eliminate the 1-hydroxy group and the simultaneous introduction of 
bromide into the 2-position of 109. This thus far unknown nucleophilic substitution reaction was 
discovered by treating 109 with POBr3 culminating in the formation of 2-bromoindole-3-carbaldehyde 
(110). Thus, 110 is now available in 4 steps from 106.5 We had already succeeded in finding the special 
reaction conditions with tips for converting 2-oxindole (111) directly into 110.5 However, 111 is 
comparatively expensive. Therefore, we developed a novel 3-step synthetic method of 111 from 107 
through 112 and 113.5 
On the basis of more than 20 years’ structure-activity relationship study on the halogen containing 
indole-3-acetic acids (IAA), indole-3-acetonitriles, and their derivatives,5 we have chosen 108—113 and 
s solution of SOMRE–16 (114), the rice roots 
times compared with the contrast when 
e 1 ppm aqueous solution of SOMRE–1 (110) was applied. We would like to apply them to all the 
plants whose roots are needed to be longer, fatter, and stronger.  
 
related compounds as “the medicine for the earth” which have the possibility to make desert full of 
plant.5 We named these intellectual properties SOMRE compounds.   
As expected, SOMRE compounds extended the root of both rice and cucumber. The former is a 
representative of monocotyledonous plant and the latter is a representative of dicotyledonous plants 
(Table 1). Thus, the 3 ppm aqueous solution of SOMRE–1 (110) lengthened the roots of rice 1.68 times 
in comparison with the control. As for the 50 ppm aqueou
became 1.46 times longer. As for the roots of cucumber, the 3 ppm aqueous solution of SOMRE–14 
(115) lengthened 1.9 times compared with the control.5  
The SOMRE compounds can be applied to various plants, vegetables, and a fruit tree. For example, a 














 50         12.5          3            0.8
14      140     168      130
146     136     120      100
Sample
168     133     113      109
  50         12.5          3            0.8
 
100     105     113       98
100     100     118      101
  
120     180     190      114
110 (SOMRE–1)
114 (SOMRE–16)
Concentration of the Sample (ppm)
Table 1. Average Root Length of Rice and Cucumber
Plant and Root 
     Length of 
       the Control
Concentration of the Sample (ppm)
                Rice 
Control: 46.8 mm (100%)
          Cucumber 
Control: 12.1 mm (100%)
115 (SOMRE–14)
6．Our Intellectual Properties Meeting “Our Five Dreams”  
As we mentioned above, we were able to create intellectual properties with the possibility that could 
achieve our five dreams.57 For the first dream to develop the medicine for making desert green and food 
increase in production, we now have both SOMRE compounds58 and SST-VED compounds.59,60 For the 
second dream to develop drugs for cardiovascular system disease, 1-hydroxyindoles61,62 are prepared. 
SST-VED compounds can be applied to the third dream for production of dementia therapeutic 
drugs.59,60 The fourth dream to get medicine of lifestyle-related disease (diabetes, osteoporosis) would be 
h 
realized by SSH-BM compounds.63,64,65 For the fifth dream to develop medicines for cancer and virus 
diseases, 1-hydroxyindoles61,62 and SST-VED compounds59,60 are prepared.58 
Here we wish to mention in detail only about the first dream, making desert full of plants.66 In recent 
years Gobi desert in Inner Mongolia in China is spreading rapidly. It is crying necessity for all life living 
on earth to stop global warming and to prevent the outbreak of the yellow sand from this area, whic
pours into any place not only Japan but also all nations on the earth. The best way to cure the global 
warming is to make the desert and sterile land green with full of plants which absorb carbon dioxide.  
Our philosophy combating desertification is quite different from the way of other groups working on 
desert in the following six points.66 1) We do not destroy natural vegetation. We do not use the plant 
which did not grow wild at the spot from old days. The success in introduction of plants growing in other 
countries means the destruction of the original environment of the native land. 2) We plant trees in wet 
season and get water under natural conditions. We revive the desert slowly to the old green environment. 
We do not take the method to pump up subsurface water and to irrigate. It promotes desertification 
because water level under the ground gradually lower or hastens the drying up of the subsurface water. 
We know from the past many failures that watering too much caused salt accumulation resulting in the 
formation of the sterile earth. 3) We do not use a polymer as water absorbent. The polymer is at great 
risk of being disintegrated by soil bacteria to generate acrylic acid, acetic acid, etc. which are harmful to 
man and beast, and they form acidic land where plants can not grow. 4) We don’t play with local soil. 
When we use ameliorant, such ingredient as an organic and an inorganic substance changes the 
ingredient ratio of the local soil. As a result, local microbe environment changes and the original 
environment is lost for ever. In addition, yellow sand absorbed the above chemicals, ingredients, and 
newly born microbes would pour into many places of the world. 5) We create a non-toxic root extension 
agent drawing the growth ability that plants originally possess. 6) We create a breeding medicine for 
goats and at the same time achieve the increasing in the cashmere-growth. The goat is the income source 
of the nomad. However, the goat is known to eat plants completely and promotes desertification. If we 
could promote the goat to breed a lot for meat production and to raise the volume of cashmere-wool per a 
ontrol), respectively. Experiment farmland was divided into 5 parts as well. Seeds of each group were 
separately sprinkled to the divided farmlands on ditches of 5 cm depth and they were covered with sand.  
 
goat while eating the same quantity of plants, we could reduce the head count of the goat guaranteeing 
the life of the nomad.  
With our intellectual properties and ample fundamental data in hand, we performed six times of 
preliminary experiments from July 2005 to May 2007 at Gobi desert in Inner Mongolia with the 
cooperation of an NPO group and the local government.66 We applied SOMRE compounds to the seeds 
of wild plant Calligonum alaschanicum (a kind of sand jujube) at Gobi desert and tested repeatedly. In 
the typical trial, seeds were divided into 5 groups and each group was dipped for 30 min into the 1, 3, 10 
ppm aqueous solution of SOMRE–1, a 2 ppm aqueous solution of IAA (the reference), and H2O (the 
c
     Sample
Root
H2O
   IAA
  2 ppm
SOMRE–1
   10 ppm
SOMRE–1
     3 ppm
SOMRE–1
     1 ppm
   
Length 
 (L cm) 18.0 21.0 22.5 36.0 42.5
 Width 
(D mm) 1.5 1.2 1.5 2.0 6.0
 D1/2 
(mm) 1.0 1.0 0.8 2.0 4.0
Weight 





Planting: August 2, 2005. Digging: October 14, 2005
Table 2. Plant Growth for 73 Days at Gobi Desert in Inner Mongolia
 
 
They were brought up for 73 days (from August 2 to October 14, 2005) under natural environment of the 
desert except for watering every one-week. We then dug grown young plants and compared the average 
root length. The results are summarized in Table 2, which clearly shows that SOMRE–1 has a 
remarkable effect on the plant’s root growth. Especially, the 1 ppm aqueous solution encouraged the 
plant’s root about 2 times longer and 8—15 times heavier than those of the reference and the control.  
With these successful results in hand, we continued preliminary field experiment to make Gobi desert 
green. Our compounds (SOMRE–1, –4, related compounds) make the wild plant’s roots longer enough 
to reach to the moisture part in the depth of around 30—40 cm from the earth surface of the desert. It is 
well known at Gobi desert that the plants grown from the seeds during wet season must experience hot 
summer and severe cold winter. Usually wild plants freeze to death in winter because of the shortage of 
root length. In between May 2006 and April 2007, we confirmed that the plants grown from the seeds 
treated with SOMRE–1 had sufficient length of the root, three times of longer root (53.2 cm) than the 
control (19.1 cm), and survived without freezing to death through cold winter. They gave bud in spring 
and proved to be able to survive through a year! The ability of the extension agent, which make roots 
e observed their growth. Two months later, their survival rate is 87.6%, 
is not 0%, instead surprisingly more than 
ke silk and the quality is 
high.68 Furthermore, the goats taking SST-VED-1 became bigger than the control group. The fecundity 
of the taking goats became excellent. They made a lot of children, as desired.69 
reach to a moisture part of the underground, decides the success or failure in the combating 
desertification.  
In April 2007, we dipped young plant’s roots of 2,700 sand jujubes into the 1 ppm aqueous solution of 
SOMRE–1 for 30 min and planted them at about 2 hectares of Gobi desert. Under natural environment 
without artificial watering w
much better than 78.3% of the control group.69 It is however impossible to dig holes and plant trees in 
each of them in global size.  
The first trial in the world was carried out throwing seeds on the dune surface of Gobi desert while 
walking in the end of May 2007. The seeds were soaked in the 1 ppm aqueous solution of SOMRE–1 in 
advance.69 After having left them under natural conditions for two months, an impressive result was 
obtained at the beginning of August. Their germinating rate 
0.1%. This experiment means that we succeeded in the preliminary experiment to sow seeds from 
airplane to Gobi desert, and then to the deserts in the world.  
On the other hand, we bought in total eight male goats and carried out feeding experiments67 in two 
farms that located distantly from each other. At the one farm 6 goats (age 0.5) were divided into two 
groups. The one group is taking 1 mg of SST-VED-1 every day, while the other is the non-taking 
control group. At the other farm, 2 goats (age 2.0) were divided into two groups. The one is taking 1 mg 
of SST-VED-1 every day, while the other is the non-taking control. After one-year cultivation the 
weight of cashmere was examined and the results are summarized in Table 3. It is evident that 
SST-VED-1 increased the growth of cashmere. Besides, the cashmere shines li
2006.7(Age 0.5, Male) ~ 2007.5
Weight of Cashmere (g)











   Goat
At Gobi Desert in Inner Mongolia, China
2006.5 (Age 2, Male ~ 2007.5
Weight of Cashmere (g)




Goat taking SST-VED–1 Control Group
Table 3. Comparison of the Growth of Cashmere
 
We hope SST-VED and SOMRE compounds would change Gobi desert again to the area with full of 
plants as it was 300 years ago. They would be useful for preventing disastrous global warming and for 
production of more food as a new technology. In addition the SOMRE compounds would be useful new 
probe for understanding the growth of plants. We believe SOMRE compounds become “the medicine 
for the earth.” 
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